Potential Drug-Drug Interaction (PDDI) CDS IG : STU1 Ballot 2, published by HL7 Clinical Decision Support Workgroup. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/PDDI-CDS/ and changes regularly. See the Directory of published versions
Official URL: http://hl7.org/fhir/uv/pddi/ValueSet/valueset-lansoprazole | Version: 1.0.0-ballot | |||
Draft as of 2018-07-02 | Computable Name: Valueset_lansoprazole | |||
Copyright/Legal: (copyright expectations unknown) |
ValueSet containing drug identifiers for lansoprazole.
References
http://www.nlm.nih.gov/research/umls/rxnorm
Code | Display |
83156 | Prevacid |
757969 | {4 (Amoxicillin 500 MG Oral Capsule [Trimox]) / 2 (Clarithromycin 500 MG Oral Tablet [Biaxin]) / 2 (lansoprazole 30 MG Delayed Release Oral Capsule [Prevacid]) } Pack [Prevpac] |
758486 | {7 (lansoprazole 15 MG Delayed Release Oral Capsule) / 14 (Naproxen 375 MG Oral Tablet) } Pack |
758497 | {7 (lansoprazole 15 MG Delayed Release Oral Capsule) / 14 (Naproxen 500 MG Oral Tablet) } Pack |
757968 | {4 (Amoxicillin 500 MG Oral Capsule) / 2 (Clarithromycin 500 MG Oral Tablet) / 2 (lansoprazole 30 MG Delayed Release Oral Capsule) } Pack |
17128 | lansoprazole |
206205 | lansoprazole 15 MG Disintegrating Oral Tablet [Prevacid] |
206206 | lansoprazole 30 MG Delayed Release Oral Capsule [Prevacid] |
596918 | lansoprazole 15 MG Delayed Release Oral Capsule [Prevacid] |
866152 | lansoprazole 30 MG Disintegrating Oral Tablet [Prevacid] |
541184 | lansoprazole 15 MG [Prevacid] |
541188 | lansoprazole 30 MG [Prevacid] |
379705 | lansoprazole Delayed Release Oral Capsule [Prevacid] |
844359 | lansoprazole Disintegrating Oral Tablet [Prevacid] |
311277 | lansoprazole 30 MG Delayed Release Oral Capsule |
351260 | lansoprazole 30 MG Disintegrating Oral Tablet |
351261 | lansoprazole 15 MG Disintegrating Oral Tablet |
596843 | lansoprazole 15 MG Delayed Release Oral Capsule |
791878 | lansoprazole 0.5 MG/ML Oral Suspension |
791880 | lansoprazole 1 MG/ML Oral Suspension |
477260 | lansoprazole 6 MG/ML Injectable Solution |
343086 | lansoprazole 15 MG |
343108 | lansoprazole 30 MG |
353363 | lansoprazole 1 MG/ML |
353364 | lansoprazole 0.5 MG/ML |
477261 | lansoprazole 6 MG/ML |
378648 | lansoprazole Delayed Release Oral Capsule |
477263 | lansoprazole Injectable Solution |
562810 | lansoprazole Oral Suspension |
706238 | lansoprazole Disintegrating Oral Tablet |
1162543 | lansoprazole Injectable Product |
1162544 | lansoprazole Oral Liquid Product |
1162545 | lansoprazole Oral Product |
1162546 | lansoprazole Pill |
1295364 | lansoprazole Disintegrating Oral Product |
1177101 | Prevacid Oral Product |
1177102 | Prevacid Pill |
1296812 | Prevacid Disintegrating Oral Product |
Expansion based on codesystem RxNorm version ??rx1
This value set contains 38 concepts.
Explanation of the columns that may appear on this page:
Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
Code | The code (used as the code in the resource instance) |
Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
Definition | An explanation of the meaning of the concept |
Comments | Additional notes about how to use the code |